Project Details
Description
Effect of ITPKb inhibitors and anti-IL2 antibodies in models of chronic graft vs. host disease
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/11 → 3/31/14 |
Funding
- NOVARTIS PHARMA AG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.